Table: Medrx -2023 group results

Medrx

09/02/2024 06:00

Feb 9 (Reuters)- 
          Medrx.Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT     
              Dec 31, 2023    Dec 31, 2022    Dec 31, 2024       YEAR       
                 LATEST         YEAR-AGO         COMPANY         COMPANY    
                 RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales          29 mln          59 mln          200 mln          1 mln     
               (-50.3 pct)    (+612.4 pct)    (+678.2 pct)     (+14.4 pct)  
  Operating   loss 933 mln      loss 1.10       loss 1.43     loss 782 mln  
  Recurring   loss 930 mln      loss 1.11       loss 1.38     loss 741 mln  
  Net
  Net         loss 932 mln      loss 1.11       loss 1.39     loss 742 mln  
  EPS        loss 26.82 yen  loss 43.81 yen  loss 36.14 yen  loss 19.36 yen 
  Ann Div          NIL             NIL             NIL                      
  -Q2 Div          NIL             NIL             NIL                      
  -Q4 Div          NIL             NIL             NIL                      
  
  NOTE - Medrx.Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T